health
Fármaco diseñado para Covid-19 puede funcionar contra Nipah
Los científicos chinos han concluido que un fármaco diseñado para el covid-19 puede funcionar contra el mortífero virus Nipah, que se ha registrado en la India y no tiene cura, reportó SCMP.
TL;DR
- A Chinese drug, VV116, originally for COVID-19, has shown efficacy against the Nipah virus.
- Studies in golden hamsters demonstrated that VV116 increased survival rates by 66.7% and reduced viral load in lungs, spleen, and brain.
- The oral pill could serve as a preventative measure for high-risk individuals like healthcare workers and as a treatment for Nipah virus outbreaks.
- The Nipah virus is highly lethal, with a fatality rate between 40% and 75%, and currently has no specific vaccine or antiviral treatment.
- Nipah virus symptoms include fever, headache, cough, sore throat, and respiratory distress, with severe complications like encephalitis.